ThoRAciC Trauma IntubatiON Risk Score for Blunt Trauma (TRACTIONS)

January 30, 2024 updated by: Azienda Usl di Bologna
The primary objective of this study is the evaluation of risk factors associated with orotracheal intubation in blunt chest trauma patients not intubated on the field and not fulfilling the criteria for intubation based on the Glasgow Coma scale score with the building of a predictive score based on those findings taking into account the clinical, laboratory and radiologic tests performed within 6 hours from hospital admission.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

Multicentre, prospective, observational study. All the consecutive blunt thoracic trauma patients consecutively admitted at the participating institutions' Emergency Department (ED) will be considered for enrolment. The primary outcome measure will be the need for orotracheal intubation for primary respiratory failure lasting at least 48 hours within 7 days after trauma. The secondary outcome measures related to analgesia are: the basal analgesia protocol received during the first 7 days from ED admission and the median cumulative dose of morphine-equivalents received as rescue therapy during the first 7 days after trauma. The secondary outcome measure related to the sonographic evolution of thoracic lesions is the global and regional LUS.

Study Type

Observational

Enrollment (Estimated)

1000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Bologna, Italy, 40100
        • Recruiting
        • Azienda Unità Sanitaria Locale
        • Contact:
          • Lorenzo Gamberini

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

chest trauma, blunt

Description

Inclusion Criteria:

  • Blunt thoracic trauma with a documentable lesion (T-AIS ≥ 2)
  • Age ≥ 18 years
  • GCS > 8 at ED admission
  • Total body CT scan available performed within 6 hours from ED admission

Exclusion Criteria:

  • - Penetrating thoracic trauma
  • Age < 18 years
  • GCS <= 8 at ED admission
  • Patients already intubated at ED arrival
  • Do not intubate order, for any reason
  • Intubation for Urgent/Emergent surgery within 24 hours from hospital arrival

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
intubated within day 7th
patients needing oro-tracheal intubation within day 7th from admission.
chest trauma requiring oro tracheal intubation
non intubated within day 7th
patients not requiring intubation within day 7th from admission

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
needing for oro-tracheal intubation within day 7th from admission
Time Frame: 7 days
7 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2022

Primary Completion (Estimated)

October 1, 2024

Study Completion (Estimated)

October 1, 2024

Study Registration Dates

First Submitted

November 25, 2022

First Submitted That Met QC Criteria

November 25, 2022

First Posted (Actual)

December 6, 2022

Study Record Updates

Last Update Posted (Actual)

January 31, 2024

Last Update Submitted That Met QC Criteria

January 30, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 4860 - TRACTIONS

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Trauma Chest

Clinical Trials on oro tracheal intubation

3
Subscribe